HPV vaccine cuts cervical cancer by 87 percent in 'historic' UK study


A British initiative to vaccinate teenage girls against the human papillomavirus (HPV) slashed cervical cancer rates by 87 percent when the vaccine was administered at age 12 and 13, 62 percent when offered at age 14 to 16, and 34 percent among women vaccinated at 16 to 18, researchers reported Thursday in the medical journal The Lancet. Cancer Research UK, which funded the study, called the results "historic" and said it proves the HPV vaccine saves lives.
Britain's National Health Service began offering the HPV vaccine to girls as young as 11 in 2008, and the new study compares cervical cancer outcomes between vaccinated and unvaccinated women now that the first cohort is in their 20s. Most cervical cancer is caused by one of two HPVs blocked by the vaccine, and immunization is much more effective if administered before teens become sexually active.
The Lancet study estimated that by June 2019, the vaccine had prevented 450 cases of cervical cancer in the immunized groups and 17,200 cases of precancerous cervical carcinomas. Cervical cancer is the No. 4 most common cancer in women worldwide and kills 300,000 each year, BBC News reports. Almost 90 percent of those deaths are in low- to middle-income countries, where the vaccine could have the biggest impact.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"We've known for many years that HPV vaccination is very effective in preventing particular strains of the virus, but to see the real-life impact of the vaccine has been truly rewarding," said lead author Peter Sasieni, of King's College London. "Assuming most people continue to get the HPV vaccine and go for screening, cervical cancer will become a rare disease."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
The best shows to see at Edinburgh Fringe 2025
The Week Recommends The world's biggest arts festival is back with an incredible line-up
-
Wonsan-Kalma: North Korea's new 'mammoth' beach resort
Under the Radar Pyongyang wants to boost tourism but there won't be many foreign visitors to Kim Jong Un's 'pet project'
-
The 5 best TV reboots of all time
The Week Recommends Finding an entirely new cast to play beloved characters is harder than it looks
-
Cytomegalovirus can cause permanent birth defects
The Explainer The virus can show no symptoms in adults
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts